Sign in
CompletedNo phase

Effect of Trypan Blue on Corneal Endothelial Cell Count During Phacoemulsification

Key facts

Who runs it
Hayat Abad Medical Complex, Peshawar
Where
Pakistan1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
60 people enrolled
Started
22 Mar 2024
Ended
22 Sept 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Trypan Blue
  • Phacoemulcification
Record updated
30 July 2026

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (13)Hide the full registry criteria

Who can take part

  • Adults aged 45 to 75 years
  • Diagnosed with age-related cataract
  • Scheduled to undergo phacoemulsification with posterior chamber intraocular lens implantation
  • Able and willing to provide written informed consent

Who cannot take part

  • Previous ocular surgery
  • Diabetes mellitus
  • Pre-existing corneal endothelial disease
  • Any other ocular pathology that could affect corneal endothelial cell count or interfere with study outcomes
  • Glaucoma
  • Corneal opacity
  • Uveitis
  • Traumatic cataract
  • Complicated cataract

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This randomized controlled trial evaluated the effect of trypan blue on corneal endothelial cell count in patients undergoing phacoemulsification for age-related cataract. Sixty participants were randomly assigned to undergo phacoemulsification either with trypan blue-assisted anterior capsule staining or without trypan blue. The primary objective was to compare postoperative corneal endothelial cell count between the two groups using specular microscopy to determine whether trypan blue has an effect on corneal endothelial cell loss during cataract surgery.

The 2 groups in the trial

  • Trypan Blue GroupTreatment being tested

    Participants underwent standard phacoemulsification with intracameral trypan blue staining of the anterior lens capsule before capsulorhexis, followed by intraocular lens implantation using a standardized surgical technique

    Treatment: Trypan Blue and Phacoemulcification

  • Control GroupExisting treatment, for comparison

    Participants underwent standard phacoemulsification without trypan blue staining of the anterior lens capsule, followed by intraocular lens implantation using the same standardized surgical technique.

    Treatment: Phacoemulcification

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
30 July 2026